Clinical Trial Update: Oral β-Alanine Supplementation in Patients With COPD [NA]

View source ↗

Summary

A clinical trial studying oral beta-alanine supplementation in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• beta-alanine (beta-alanine)

Snippet

Sponsor: Hasselt University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | NA | Status: COMPLETED